Suppr超能文献

国家结核病参比实验室诊断工具更新情况调查,重点关注世卫组织 2007 年推荐的快速菌种鉴定检测方法。

Survey of the diagnostic retooling process in national TB reference laboratories, with special focus on rapid speciation tests endorsed by WHO in 2007.

机构信息

Royal Tropical Institute, Royal Tropical Institute Biomedical Research, Amsterdam, The Netherlands.

出版信息

PLoS One. 2012;7(8):e43439. doi: 10.1371/journal.pone.0043439. Epub 2012 Aug 24.

Abstract

BACKGROUND

Successful integration of new diagnostics in national tuberculosis (TB) control programs, also called 'retooling', is highly dependent on operational aspects related to test availability, accessibility and affordability. This survey aimed to find out whether recommendations to use new diagnostics lead to successful retooling in high TB endemic countries, using immunochromatographic tests (ICTs) for TB culture speciation as a case study. ICTs are recommended to accurately confirm the presence of bacteria of the Mycobacterium tuberculosis complex in liquid culture isolates.

METHODS AND FINDINGS

Questionnaires were sent to national TB reference laboratories (NRLs) in 42 high TB endemic countries to address their access to information on ICT implementation, logistics related to availability, accessibility and affordability of ICTs, and testing algorithms. Results from 16 responding countries indicated that half of the NRLs were aware of the contents of WHO guidance documents on liquid culture and ICT implementation, as well as their eligibility for a negotiated pricing agreement for ICT procurement. No major issues with availability and accessibility of ICTs were raised. When asked about testing algorithms, ICTs were not used as stand-alone or first test for TB culture identification as recommended by WHO.

CONCLUSIONS

The low response rate was a limitation of this survey and together with NRLs managers' unawareness of global guidance, suggests a lack of effective communication between partners of the global laboratory network and NRLs. TB tests could become more affordable to high TB endemic countries, if the possibility to negotiate lower prices for commercial products is communicated to them more successfully. NRLs need additional guidance to identify where available technologies can be most usefully implemented and in what order, taking into account long-term laboratory strategies.

摘要

背景

新诊断方法在国家结核病(TB)控制规划中的成功整合,也称为“重新装备”,高度依赖于与检测的可用性、可及性和可负担性相关的操作方面。本调查旨在探讨使用新诊断方法是否会导致高结核病流行国家的成功重新装备,以免疫色谱检测(ICT)用于结核分枝杆菌复合群的培养物特异性为例。推荐 ICT 用于准确确认液体培养物分离物中细菌的存在。

方法和发现

向 42 个高结核病流行国家的国家结核病参考实验室(NRL)发送了调查问卷,以了解它们获取关于 ICT 实施的信息、与 ICT 的可用性、可及性和可负担性相关的后勤问题,以及检测算法。来自 16 个回应国家的结果表明,一半的 NRL 了解世卫组织关于液体培养和 ICT 实施的指导文件的内容,以及它们有资格获得 ICT 采购的谈判定价协议。没有提出关于 ICT 的可用性和可及性的重大问题。当被问及检测算法时,ICT 并未像世卫组织建议的那样,作为结核培养物鉴定的独立或首次检测使用。

结论

低响应率是本调查的一个限制,加上 NRL 管理人员对全球指导的认识不足,表明全球实验室网络的合作伙伴与 NRL 之间缺乏有效的沟通。如果将与商业产品谈判较低价格的可能性更有效地传达给高结核病流行国家,那么结核病检测可能会变得更加负担得起。NRL 需要额外的指导,以确定在哪里可以最有效地实施现有技术,以及按照什么顺序实施,同时考虑到长期的实验室战略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/926e/3427371/ec8838cea2ce/pone.0043439.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验